跳至主要内容
临床试验/JPRN-UMIN000013693
JPRN-UMIN000013693已完成未知

Adding smartphone cognitive-behavior therapy to pharmacotherapy for major depression: A randomized control trial - FLATT1

Japan Foundation of Neuroscience and Mental Health0 个研究点目标入组 164 人开始时间: 2014年6月1日最近更新:
适应症

试验速览

阶段
未知
状态
已完成
发起方
入组人数
164

研究概览

简要总结

Please see: Mantani A, Kato T, Furukawa TA, Horikoshi M, Imai H, Hiroe T, Chino B, Funayama T, Yonemoto N, Zhou Q & Kawanishi N (2017) Smartphone Cognitive Behavioral Therapy as an Adjunct to Pharmacotherapy for Refractory Depression: Randomized Controlled Trial. Journal of Medical Internet Research, 19, e373.

研究设计

研究类型
Interventional

入排标准

年龄范围
25years-old 至 59years-old(—)
性别
All

入选标准

  • 未提供

排除标准

  • 1) Treatment with monoamine oxidase inhibitors, electroconvulsive therapy , repetitive transcranial magnetic stimulation, escitalopram/sertraline or individual face-to-face cognitive-behavior or interpersonal therapy during the index episode 2) Psychiatric omorbidities 2-1) Lifetime diagnosis of schizophrenia, schizoaffective disorder or bipolar disorder 2-2) Current diagnosis of neurocognitive disorder, eating disorder, substance dependence or borderline personality disorder 3) Imminent risk of suicide 4) Physical comorbidities that interfere with escitalopram treatment 4-1) prolonged QTc (>450 ms for men, and >470 for women) 4-2) co-administration of drugs known to cause QTc prolongation as judged by treating physician 5) Pregnant or breast-feeding women 6) Current participation in another clinical intervention research

研究者

发起方
Japan Foundation of Neuroscience and Mental Health

相似试验